PureTech Health plc (PRTC) Operating Leases (2019 - 2024)

PureTech Health (PRTC) has disclosed Operating Leases for 3 consecutive years, with $29.1 million as the latest value for Q4 2022.

  • On a quarterly basis, Operating Leases fell 11.71% to $29.1 million in Q4 2022 year-over-year; TTM through Dec 2022 was $29.1 million, a 11.71% decrease, with the full-year FY2022 number at $29.1 million, down 11.71% from a year prior.
  • Operating Leases was $29.1 million for Q4 2022 at PureTech Health, down from $33.0 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $35.3 million in Q4 2020 to a low of $29.1 million in Q4 2022.
  • A 3-year average of $32.5 million and a median of $33.0 million in 2021 define the central range for Operating Leases.
  • Peak YoY movement for Operating Leases: decreased 6.67% in 2021, then decreased 11.71% in 2022.
  • PureTech Health's Operating Leases stood at $35.3 million in 2020, then fell by 6.67% to $33.0 million in 2021, then dropped by 11.71% to $29.1 million in 2022.
  • Per Business Quant, the three most recent readings for PRTC's Operating Leases are $29.1 million (Q4 2022), $33.0 million (Q4 2021), and $35.3 million (Q4 2020).